Nova Ljubljanska Banka d.d. (LON:NLB)

Market Cap	2.86B
Revenue (ttm)	1.07B
Net Income (ttm)	418.59M
Shares Out	n/a
EPS (ttm)	20.91
PE Ratio	6.83
Forward PE	6.73
Dividend	2.02 (18.00%)
Ex-Dividend Date	Jun 20, 2025

Volume	n/a
Average Volume	19,249
Open	n/a
Previous Close	11.20
Day's Range	11.20 - 11.20
52-Week Range	11.20 - 26.50
Beta	0.61
RSI	61.03
Earnings Date	Aug 7, 2025

About Theseus Pharmaceuticals

Nova Ljubljanska Banka d.d., together with its subsidiaries, provides various banking services for retail and corporate clients in Slovenia, South East Europe, and Western Europe. It operates through Retail Banking in Slovenia, Corporate and Investment Banking in Slovenia, Strategic Foreign Markets, Financial Markets in Slovenia, Non-Core Members, and Other segments. The company offers saving, deposit, and business accounts; and personal, home, and green housing loans. It also provides credit, debit, and deferred payment cards; savings and inve...

• Industry: Banks - Regional
• Sector: Financials
• Founded: 1889
• Employees: 8,322
• Stock Exchange: London Stock Exchange
• Ticker Symbol: NLB

Financial Performance

In 2024, LON:NLB's revenue was 1.28 billion, an increase of 8.18% compared to the previous year's 1.18 billion. Earnings were 514.55 million, a decrease of -6.56%.